EARLY CLINICAL RESULTS AND PRECLINICAL VALIDATION OF THE O-GLCNACASE (OGA) INHIBITOR MK-8719 AS A NOVEL THERAPEUTIC FOR THE TREATMENT OF TAUOPATHIES
暂无分享，去创建一个
Dawn M. Toolan | Joseph James Duffy | J. Renger | Sean M. Smith | D. Schoepp | D. Vocadlo | H. Selnick | C. Salinas | Jacob N. Marcus | J. Schachter | Xiaohai Wang | Wenping Li | A. Struyk | R. Declercq | Fred J Hess | D. Jonathan | M. Forman | Michelle S. Pearson | E. McEachern | Mali L Cosden | Hostetler D. Eric